Nicholas Company, Inc. Astrazeneca PLC Transaction History

Nicholas Company, Inc.

  • $5.71 Billion
  • Q2 2025

A detailed history of Nicholas Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Company, Inc. holds 1,139,599 shares of AZN stock, worth $84.4 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
1,139,599
Previous 1,161,009 1.84%
Holding current value
$84.4 Million
Previous $85.3 Million 6.68%
% of portfolio
1.39%
Previous 1.55%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
SELL
$64.87 - $75.0 $1.39 Million - $1.61 Million
-21,410 Reduced 1.84%
1,139,599 $79.6 Million
Q4 2024

Feb 10, 2025
BUY
$63.2 - $79.58 $10.8 Million - $13.6 Million
171,199 Added 17.3%
1,161,009 $76.1 Million
Q3 2024

Nov 12, 2024
SELL
$76.67 - $87.62 $445,836 - $509,510
-5,815 Reduced 0.58%
989,810 $77.1 Million
Q1 2024

May 14, 2024
BUY
$61.03 - $69.57 $10.3 Million - $11.7 Million
168,000 Added 20.3%
995,625 $67.5 Million
Q4 2023

Feb 13, 2024
BUY
$61.89 - $69.28 $43.8 Million - $49 Million
707,215 Added 587.34%
827,625 $55.7 Million
Q3 2023

Feb 13, 2024
SELL
$64.85 - $71.7 $34,046 - $37,642
-525 Reduced 0.43%
120,410 $8.15 Million
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $34,046 - $37,642
-525 Reduced 0.43%
120,410 $8.15 Million
Q1 2023

Feb 13, 2024
BUY
$63.15 - $71.6 $4,104 - $4,654
65 Added 0.05%
120,935 $8.39 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $4,104 - $4,654
65 Added 0.05%
120,935 $8.39 Million
Q4 2022

Feb 13, 2024
BUY
$54.21 - $70.44 $271,050 - $352,200
5,000 Added 4.32%
120,870 $8.19 Million
Q4 2022

Feb 09, 2023
BUY
$54.21 - $70.44 $271,050 - $352,200
5,000 Added 4.32%
120,870 $8.19 Million
Q3 2022

Feb 13, 2024
BUY
$53.02 - $135.75 $2.4 Million - $6.15 Million
45,340 Added 64.28%
115,870 $6.35 Million
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $2.4 Million - $6.15 Million
45,340 Added 64.28%
115,870 $6.35 Million
Q1 2022

Feb 13, 2024
SELL
$55.72 - $67.12 $2.78 Million - $3.35 Million
-49,880 Reduced 41.43%
70,530 $4.68 Million
Q1 2022

May 11, 2022
BUY
$55.72 - $67.12 $3.93 Million - $4.73 Million
70,530 New
70,530 $4.68 Million

Others Institutions Holding AZN

# of Institutions
1,422
Shares Held
509M
Call Options Held
9.82M
Put Options Held
3.14M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $230B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email